Identifying Genetic Biomarkers
GeneGini enables Academic and Pharmaceutical Researchers to prognose, diagnose and sub-categorise more diseases with better accuracy and sensitivity.
Health and BiotechLife SciencesPharma
Novel Anti-TB Therapeutics
This project focuses on the development of drugs that target novel, unexplored biological pathways to treat Tuberculosis and tackle the global threat of drug resistant TB.
Sight for spore eyes - Fungal keratitis treatment
Damage to the eye as a result of fungal infection remains a pressing issue, with early intervention not always being possible and long-term vision loss being common. This new technology can be the quick and accurate intervention needed to prevent permanent impairment.
Touching a nerve - Polynerve
Surgery to take nerves from one area of the body to replace those lost in another are a common solution for nerve injuries. However, these surgeries incur their own difficulties, such as loss of sensation and pain. Polynerve is a new device which will revolutionise the field of nerve repair.
Targeted cancer therapy - ManTRa DX
ManTRa DX have developed tumour-site-specific gene expression signatures to assess hypoxia which has the potential to deliver major advances in personalised cancer medicine.
Vision quest - Caspar's Castle
Testing the visual field of children is difficult, resulting in inaccurate and unreliable outcomes which can lead to sight loss and other conditions. The University of Manchester has hopes to change that with novel software which is quite the spectacle.